Gastrointestinal Market Research Reports & Industry Analysis
While many of these illnesses are chronic and can only be treated medically, more holistic and natural approaches are being used more frequently to prevent and manage gastrointestinal disorders. Many healthcare providers are recommending stress management, a healthy diet, and exercise to prevent and manage symptoms.
Exercise has shown to decrease the risk of colon cancer, minimize constipation and improve overall GI health. Even minimal exercise paired with a healthy diet of fruits, vegetables, low fat protein and avoidance of red meat, animal fat, and processed meats, can go a long way in preventing colon cancer and other GI diseases.
It is known that psychological stress can aggravate symptoms of Crohn’s disease, irritable bowel syndrome, and ulcerative colitis. Taking a mind-body approach to health can help these patients manage their illnesses. Techniques such as yoga, meditation, massage, and acupuncture can lower stress and in turn reduce bowel symptoms. Doctors also recommend an anti-inflammatory diet (omega-3 fatty acids, fruits & vegetables, and protein rich food like fish, chicken and soy) for people suffering from Crohn’s disease.
Gastrointestinal Industry Research & Market Reports
-
Latin America, Middle East & Africa Digestive Health Supplements Market Databank
... CAGR of 2.88% from 2021 to 2029. OTC segment is expected to be the highest contributor to this market, with $7,232.0 Million in 2020, and is anticipated to reach $9,376.0 Million by 2029, registering a ... Read More
-
Global Digestive Health Supplements Market Databank
... to 2029. OTC segment is expected to be the highest contributor to this market, with $7,232.0 Million in 2020, and is anticipated to reach $9,376.0 Million by 2029, registering a CAGR of 2.97%. The report ... Read More
-
Europe Digestive Enzyme Supplements Market Databank
... to 2029. Plant segment is expected to be the highest contributor to this market, with $20.3 Million in 2020, and is anticipated to reach $28.6 Million by 2029, registering a CAGR of 3.91%. Animal segment ... Read More
-
Asia-Pacific Digestive Enzyme Supplements Market Databank
... to 2029. Plant segment is expected to be the highest contributor to this market, with $20.3 Million in 2020, and is anticipated to reach $28.6 Million by 2029, registering a CAGR of 3.91%. Animal segment ... Read More
-
Leading Digestive Health Products Country Markets Databank
... 2021 to 2029. Europe is expected to be the highest contributor to this market, with $611.8 Million in 2020, and is anticipated to reach $732.9 Million by 2029, registering a CAGR of 2.06%. Asia-Pacific is ... Read More
-
Pressure Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Pressure Ulcers (Dermatology) pipeline landscape. Pressure ulcers are an injury that breaks down the skin and underlying tissue. The ... Read More
-
Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Diarrhea (Gastrointestinal) pipeline landscape. Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to ... Read More
-
Opioid-Induced Constipation (OIC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Opioid-Induced Constipation (OIC) (Toxicology) pipeline landscape. Opioids are effective pain relievers, but often have the side effect ... Read More
-
Functional (Non Ulcer) Dyspepsia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Functional (Non Ulcer) Dyspepsia (Gastrointestinal) pipeline landscape. Non-ulcer dyspepsia is a term used to describe ... Read More
-
Chemotherapy Induced Nausea and Vomiting Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Vomiting - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline landscape. Chemotherapy induced nausea and vomiting ... Read More
-
Reflux Esophagitis (Gastroesophageal Reflux Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Disease) - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Reflux Esophagitis (Gastroesophageal Reflux Disease) (Gastrointestinal) pipeline landscape. When the liquid content of ... Read More
-
U.S. Vasopressin Market, by Type (Intravenous Injection, Intramuscular Injection, Subcutaneous Injection, and Others), by Application (Anti-diuretic Hormone Deficiency, Gastrointestinal Bleeding, Vasodilatory Shock, Ventricular Tachycardia, and Fibrillation), and by End User (Hospitals, Dental Clinics, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Vasopressin is a nonapeptide produced in the hypothalamus, exhibits diverse physiological functions related to hemodynamic modulation, diuresis, and behavior. Vasopressin is similar to oxytocin, differing ... Read More
-
Anastomosis Devices Market Size, Share & Trends Analysis Report By Product (Disposable, Reusable), By Application (Cardiovascular Surgery, Gastrointestinal Surgery), By End-user, By Region, And Segment Forecasts, 2022 - 2030
... The global anastomosis devices market size is expected to reach USD 5.84 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 5.6% from ... Read More
-
Smart Pills Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application (Capsule Endoscopy, Drug Delivery, and Patient Monitoring), Disease Indication (Gastrointestinal Diseases, Neurological Disorders, Cancer, Inherited Disorders, and Other Disease Indications), and End User (Hospitals and Clinics, Research Institutes, and Home Healthcare)
... End User (Hospitals and Clinics, Research Institutes, and Home Healthcare) The global Smart Pills market size is projected to reach US$ 9,061.29 million by 2028 from US$ 4,019.30 million in 2021. The global Smart Pills ... Read More
-
2022-2026 H. Pylori Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... volumes and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for H. Pylori tests performed in the following market segments: Hospitals Commercial/Private Labs ... Read More
-
Saudi Arabia Pharmaceutical Market; By Drug Type (Branded Drugs and Generic Drugs); By Product Type (Prescription Drugs And OTC (Over-The-Counter) Drugs); By Application (Cardiovascular, Anti-Infective, Musculoskeletal, Oncology, Metabolic Disorder, Central Nervous System, Gastrointestinal, Respiratory, Dermatology, Ophthalmology, Hematology, And Others (Nutraceutical, Dental And Veterinarian)); By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, And Online Pharmacy); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Ophthalmology, Hematology, And Others (Nutraceutical, Dental And Veterinarian)); By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, And Online Pharmacy); Trend Analysis, Competitive Market Share & Forecast, 2018-2028 Saudi Arabia Pharmaceutical Market to Reach USD 19,764 Million ... Read More
-
2022 Global: Gastrointestinal / Gi Stent - Innovative Markets Forecast (2028) report
... the period 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 ... Read More
-
Pharmaceutical Drugs Market Covering Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs; Central Nervous System Drugs; O
... 2021: Covid 19 Impact and Recovery The global pharmaceutical drugs market grew from $771.16 billion in 2015 to $975 billion in 2020 at a CAGR of 4.80%. The global pharmaceutical drugs market is expected to ... Read More
-
U.S. Hospital Emergency Department Market Size, Share & Trends Analysis Report By Insurance Type (Medicare & Medicaid, Private), By Condition (Gastrointestinal, Cardiac, Infectious, Traumatic), And Segment Forecasts, 2022 - 2030
... Grand View Research, Inc. Rising prevalence of diseases requiring immediate care such as cardiac arrest is expected to drive the growth of this market. Hospital Emergency Departments (EDs) are preferred by such individuals in need ... Read More
-
U.S. Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028 The U.S. clinical ... Read More
-
Gastrointestinal Drugs Global Market Report 2022
... and senior management with the critical information they need to assess the increasing demand for gastrointestinal drugs. Vitamins and Minerals play a crucial role in the treatment of pateints with Covid 19 as they are ... Read More
-
Traveler’s Diarrhea- Pipeline Insight, 2022
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Traveler’s Diarrhea Understanding Traveler’s ... Read More
-
Faecal Extraction Systems Market Share, Size, Trends, Industry Analysis Report, By Assay (Calprotectin, Albumin, Hemoglobin, Bile Acids, Others); By Indication; By Analysis Test; By End Use; By Region; Segment Forecast, 2022 - 2030
... faecal extraction systems market size is expected t-reach USD 2.19 billion by 2030 according t-a new study by Polaris Market Research. The report “Faecal Extraction Systems Market Share, Size, Trends, Industry Analysis Report, By Assay ... Read More
-
Saudi Arabia Disposable Endoscopy Devices Market, By Application (Gastroenterology, Urology, ENT, Gynecology, Colonoscopy, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region, Competition Forecast & Opportunities, 2027
... market is projected to register a significant growth during the forecast period. The rising demand for minimally invasive surgical and diagnostic procedures and advancements in healthcare systems are expected to drive the Saudi Arabia endoscopy ... Read More
-
Hepatic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Hepatic Encephalopathy (Gastrointestinal) pipeline landscape. Hepatic encephalopathy is a worsening of brain function that occurs when the liver is no ... Read More
Research Assistance
